These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23295318)
1. Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer. Maak M; Simon I; Nitsche U; Roepman P; Snel M; Glas AM; Schuster T; Keller G; Zeestraten E; Goossens I; Janssen KP; Friess H; Rosenberg R Ann Surg; 2013 Jun; 257(6):1053-8. PubMed ID: 23295318 [TBL] [Abstract][Full Text] [Related]
2. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors. Kopetz S; Tabernero J; Rosenberg R; Jiang ZQ; Moreno V; Bachleitner-Hofmann T; Lanza G; Stork-Sloots L; Maru D; Simon I; Capellà G; Salazar R Oncologist; 2015 Feb; 20(2):127-33. PubMed ID: 25561511 [TBL] [Abstract][Full Text] [Related]
3. Identification of patients with high-risk stage II colon cancer for adjuvant therapy. Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753 [TBL] [Abstract][Full Text] [Related]
4. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients. Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968 [TBL] [Abstract][Full Text] [Related]
5. Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence. Belt EJ; Stockmann HB; Delis-van Diemen PM; Bril H; Tijssen M; van Essen HF; Heymans MW; Beliën JA; Carvalho B; Cillessen SA; Meijer GA J Surg Oncol; 2014 Mar; 109(3):255-65. PubMed ID: 24249458 [TBL] [Abstract][Full Text] [Related]
6. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer. Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756 [TBL] [Abstract][Full Text] [Related]
7. Cell cycle proteins predict recurrence in stage II and III colon cancer. Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118 [TBL] [Abstract][Full Text] [Related]
8. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. Gray RG; Quirke P; Handley K; Lopatin M; Magill L; Baehner FL; Beaumont C; Clark-Langone KM; Yoshizawa CN; Lee M; Watson D; Shak S; Kerr DJ J Clin Oncol; 2011 Dec; 29(35):4611-9. PubMed ID: 22067390 [TBL] [Abstract][Full Text] [Related]
9. Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. Kennedy RD; Bylesjo M; Kerr P; Davison T; Black JM; Kay EW; Holt RJ; Proutski V; Ahdesmaki M; Farztdinov V; Goffard N; Hey P; McDyer F; Mulligan K; Mussen J; O'Brien E; Oliver G; Walker SM; Mulligan JM; Wilson C; Winter A; O'Donoghue D; Mulcahy H; O'Sullivan J; Sheahan K; Hyland J; Dhir R; Bathe OF; Winqvist O; Manne U; Shanmugam C; Ramaswamy S; Leon EJ; Smith WI; McDermott U; Wilson RH; Longley D; Marshall J; Cummins R; Sargent DJ; Johnston PG; Harkin DP J Clin Oncol; 2011 Dec; 29(35):4620-6. PubMed ID: 22067406 [TBL] [Abstract][Full Text] [Related]
10. Tumor budding as an index to identify high-risk patients with stage II colon cancer. Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
12. Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. Belt EJ; Fijneman RJ; van den Berg EG; Bril H; Delis-van Diemen PM; Tijssen M; van Essen HF; de Lange-de Klerk ES; Beliën JA; Stockmann HB; Meijer S; Meijer GA Eur J Cancer; 2011 Aug; 47(12):1837-45. PubMed ID: 21621406 [TBL] [Abstract][Full Text] [Related]
14. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification. Radespiel-Tröger M; Hohenberger W; Reingruber B Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance of microRNA-93 downregulation in human colon cancer. Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160 [TBL] [Abstract][Full Text] [Related]
16. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer. Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729 [TBL] [Abstract][Full Text] [Related]
17. CIMP status of interval colon cancers: another piece to the puzzle. Arain MA; Sawhney M; Sheikh S; Anway R; Thyagarajan B; Bond JH; Shaukat A Am J Gastroenterol; 2010 May; 105(5):1189-95. PubMed ID: 20010923 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of guanylyl cyclase C lymph node status for colon cancer staging and prognosis. Sargent DJ; Resnick MB; Meyers MO; Goldar-Najafi A; Clancy T; Gill S; Siemons GO; Shi Q; Bot BM; Wu TT; Beaudry G; Haince JF; Fradet Y Ann Surg Oncol; 2011 Nov; 18(12):3261-70. PubMed ID: 21533822 [TBL] [Abstract][Full Text] [Related]
19. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796 [TBL] [Abstract][Full Text] [Related]
20. A novel data-driven prognostic model for staging of colorectal cancer. Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]